ankyrin 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| exocytosis | ||
| endoplasmic reticulum to Golgi vesicle-mediated transport | ||
| cytoskeleton organization | ||
| signal transduction | ||
| positive regulation of organelle organization |
| GO Term | Evidence Code | PMID |
|---|---|---|
| axolemma | ||
| M band | ||
| sarcolemma | ||
| neuron projection | ||
| postsynaptic membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| structural molecule activity | ||
| structural constituent of cytoskeleton | ||
| protein binding | ||
| cytoskeletal anchor activity | ||
| cytoskeletal anchor activity |
| InterPro |
|---|
| Ankyrin repeat-containing domain superfamily |
| Ankyrin repeat |
| Ankyrin, UPA domain |
| Death domain |
| Death-like domain superfamily |
| ZU5 domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0110916 | hereditary spherocytosis type 1 | |
| DOID:12971 | hereditary spherocytosis | |
| DOID:2355 | anemia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026